Revision of omalizumab dosing table for dosing every 4 instead of 2 weeks for specific ranges of bodyweight and baseline IgE.

Overview
Research
Identity
Additional Document Info
View All

authors

Lowe, Philip J
Georgiou, Panayiotis
Canvin, Janice

publication date

January 1, 2014

published in

Regulatory toxicology and pharmacology : RTP Journal

has subject area